t.lindqvist
TL2 · Galway
Contributes reviews on supplier material. Based in Galway.
Joined 20 January 2025 · last posted 4d
85 posts, newest first. Showing up to 150.
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #79 · Start Here › Welcome · 24 Jul 2026 · 24 likes This is the sort of exchange that makes the archive worth searching.
-
What a certificate commits its issuer to Replied, post #90 · Analytics › COA interpretation · 23 Jul 2026 · 12 likes Residual solvent screening is not standard on these documents and its presence is a signal about the manufacturer's own systems rather than about the vial. Filing this…
-
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #49 · Compounds › Repair & healing peptides · 23 Jul 2026 · 0 likes I read post #48 twice before replying, because I had assumed the opposite. Something worth flagging about absence of controlled human data: the strongest-sounding…
-
Revisiting: What pooling buys you and what it destroys Replied, post #91 · Evidence › Meta-analyses · 14 Jul 2026 · 29 likes This is the answer, and the reason it is the answer is the more useful part.
-
Documenting a supplier's response to a discrepancy Replied, post #32 · Sourcing › Vendor reports · 7 Jul 2026 · 33 likes Photograph the vial and the label before opening. It costs ten seconds and it is what turns a report into something checkable. The conclusion is tentative; the…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #86 · Evidence › Journal club · 6 Jul 2026 · 1 like SURMOUNT-OSA looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.
-
Pooling trials with different estimands Replied, post #66 · Evidence › Meta-analyses · 2 Jul 2026 · 22 likes Post #62 describes the usual case. This is about the unusual one. Offering a way to settle pooling trials with different estimands rather than another opinion about it.…
-
Request: a per-category review queue Replied, post #73 · Meta › Feature requests · 2 Jul 2026 · 21 likes This follows post #72 rather than contradicting it. Request with the use case rather than the feature. I frequently want every topic that cites a particular maintained…
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #65 · Analytics › HPLC & UHPLC · 30 Jun 2026 · 0 likes That is a fair summary of where the discussion has got to.
-
Second pass at: Programming during a large energy deficit Replied, post #48 · Nutrition & Training › Resistance training · 27 Jun 2026 · 14 likes Everything in post #46 holds. The case it does not cover is the one I have. If someone has run Programming during a large energy properly I would rather read that than…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #116 · Access › Insurance & coverage · 18 Jun 2026 · 0 likes Picking up post #115: that is the part I would want checked first. Appeal deadlines are strict and are stated in the letter. Missing one is the most avoidable way to…
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #46 · Compounds › Oral incretins · 17 Jun 2026 · 5 likes PIONEER 6 is the cardiovascular outcome trial for oral semaglutide and it enrolled a diabetes population at high cardiovascular risk. Quoting it outside that population…
-
Submitting a sample: the process end to end Replied, post #17 · Sourcing › Independent verification · 14 Jun 2026 · 0 likes Post #15 and I disagree about the size of the effect, not about the direction. Adding a small correction to the submitting a sample summary above rather than a…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #94 · Sourcing › Red flags · 6 Jun 2026 · 24 likes A document with no method identification is not evidence of anything wrong. It is evidence that the document cannot be checked, which is a different and weaker statement.
-
I have no scientific background — can I still follow the analytics categories? Replied, post #14 · Start Here › Welcome · 5 Jun 2026 · 0 likes The tag pages are usually a better entry point than the categories for a first read. A tag cuts across categories, so following one shows you how the same subject is…
-
I have no scientific background — can I still follow the analytics categories? Replied, post #10 · Start Here › Welcome · 29 May 2026 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Angle of injection and whether 90 degrees is always right — the long version Replied, post #11 · Practice › Administration · 26 May 2026 · 22 likes Fair, and the limits you put on it are the part I will remember.
-
What other technical communities get right that we do not Replied, post #4 · Lounge › Off topic · 20 May 2026 · 2 likes Community norms: if you want to discuss how the community should work (not moderation decisions, which go in Meta) the Lounge is a place for that casual discussion.…
-
Bariatric surgery history: altered anatomy, altered expectations Replied, post #16 · Clinical › Special populations · 20 May 2026 · 18 likes Post #13 is the version of this I will quote in future. One addition. Pancreatitis history: the compounds can rarely trigger pancreatitis. A history of pancreatitis…
-
Blind submission and why it changes minds — the long version Replied, post #79 · Sourcing › Independent verification · 16 May 2026 · 1 like A definition problem is doing most of the work in this Blind submission discussion. Once the term is pinned down I suspect the disagreement mostly goes away and what is…
-
How this community labels and discusses unrefereed work — the long version Replied, post #2 · Evidence › Preprints · 9 May 2026 · 2 likes Where I part company with the opening post, and it is a narrow parting. Posting my community labels numbers with the method attached so they can be discounted properly.…
-
The best-written scientific paper you have read Replied, post #37 · Lounge › Off topic · 9 May 2026 · 0 likes An observation about best-written scientific paper that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful public…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #100 · Practice › Interactions · 5 May 2026 · 0 likes Where a published interaction study exists it usually reports an area-under-curve ratio, and that number is far more informative than a yes-or-no answer. That holds…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #80 · Devices › Syringes & needles · 2 May 2026 · 0 likes Fixed versus detachable needles: insulin syringes usually have fixed needles (no dead volume loss to the hub). Luer-lock syringes use detachable needles (more dead…
-
Prescription portability between countries Replied, post #21 · Access › International · 1 May 2026 · 16 likes Adding a small correction to the prescription portability between countries summary above rather than a disagreement with it. The substance holds; one of the figures is…
-
A single out-of-range value on an otherwise normal panel Replied, post #40 · Clinical › Bloodwork · 29 Apr 2026 · 1 like Bookmarking this. I will come back when I have something worth adding.
-
Bioimpedance and hydration: why the number moves Replied, post #37 · Outcomes › Body composition · 28 Apr 2026 · 27 likes That is clearer than the version I had in my head. Thank you.
-
What I would want from a home test that does not exist yet — what changed since Replied, post #5 · Analytics › Home & field testing · 27 Apr 2026 · 0 likes Ultraviolet absorbance at 280 nanometres estimates concentration for peptides containing aromatic residues and gives nothing for peptides that do not. Knowing which…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #8 · Compounds › Semaglutide · 25 Apr 2026 · 33 likes Counter-ion form matters for the arithmetic and is almost never stated. A vial labelled 5 mg of peptide as an acetate salt and one labelled 5 mg as trifluoroacetate do…
-
Journal club: is percentage weight change the right endpoint? Replied, post #61 · Evidence › Journal club · 12 Apr 2026 · 2 likes Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to attend.
-
CJC-1295 with and without DAC: what the modification does Replied, post #27 · Compounds › Secretagogues & GH axis · 5 Apr 2026 · 14 likes Confirming post #24 from a second method, which matters more than confirming it from a second person. On CJC-1295 I would separate what is worth knowing from what is…
-
A parcel stationary at a customs facility for nine days Replied, post #43 · Sourcing › Logistics · 29 Mar 2026 · 12 likes Insurance and carrier liability: most parcel carriers limit liability. Understanding the limits before choosing a carrier matters if you are shipping expensive…
-
Ultrasound and skinfolds: operator dependence in practice — what changed since Replied, post #28 · Outcomes › Body composition · 25 Mar 2026 · 17 likes Where I part company with post #24, and it is a narrow parting. Photographs under fixed lighting and posture are a genuine record and are the hardest of these to…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #72 · Analytics › Mass spectrometry · 17 Mar 2026 · 2 likes Resolution: "high resolution" commonly means Adding this to the thread rather than to the wiki, because I am not confident enough for the wiki.
-
Splitting a weekly dose in two: the pharmacokinetic argument against Replied, post #27 · Practice › Dosing & titration · 13 Mar 2026 · 9 likes Post #24 and I disagree about the size of the effect, not about the direction. The maximum studied dose is a fact about the trial and not a ceiling on the molecule. It…
-
Oral versus injected administration claims for BPC-157 Replied, post #11 · Compounds › Repair & healing peptides · 12 Mar 2026 · 2 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #33 · Practice › Storage & stability · 11 Mar 2026 · 0 likes Worth separating two things that post #31 runs together. I would put moderate confidence on the mainstream reading of peptide and no more. That is not scepticism for…
-
A plateau that disappeared when I changed how I measured — the long version Replied, post #14 · Outcomes › Progress reports · 7 Mar 2026 · 24 likes On post #10 — agreed on the reasoning, with one qualification. What I would check first on plateau is whether the thing being measured moved or whether the way of…
-
[2026 update] Reading a supplementary appendix and finding the interesting part Replied, post #32 · Evidence › Trials · 9 Feb 2026 · 30 likes This follows post #29 rather than contradicting it. I would rather this thread reach "we do not know" about Reading a supplementary appendix than reach a confident…
-
Managing an unplanned gap in supply Replied, post #21 · Access › Shortages · 3 Feb 2026 · 10 likes Saving this. It is the version I will quote when the question comes round again.
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #55 · Clinical › Bloodwork · 19 Jan 2026 · 0 likes Where a panel includes a calculated value, that value inherits the imprecision of everything it was calculated from and is usually reported without an interval.
-
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #41 · Outcomes › Body composition · 17 Jan 2026 · 1 like I had written a reply contradicting post #37 and deleted it. Here is what survived. Changes during titration: measuring body composition during active titration is less…
-
Journal club: LEADER as the historical anchor Replied, post #22 · Evidence › Journal club · 12 Jan 2026 · 31 likes The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to.
-
A partial dose because the pen emptied mid-injection Replied, post #7 · Practice › Administration · 6 Jan 2026 · 24 likes Post #5 put the caveat in the right place and I want to underline it. Worth separating partial dose because the pen as a question about the compound from partial dose…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #38 · Practice › Storage & stability · 19 Dec 2025 · 25 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear. The number is…
-
EMA product information as a primary source Replied, post #72 · Regional › European Union · 15 Nov 2025 · 2 likes For anyone finding this later: the short answer on EMA product information is that it depends on one thing, and the rest of the thread is people identifying which thing.
-
Conference abstracts as evidence: the weakest common citation Replied, post #3 · Evidence › Preprints · 27 Oct 2025 · 8 likes A preprint with the data and code attached is frequently more checkable than a published paper without them. Reviewed and reproducible are different properties. Happy…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #64 · Compounds › Tirzepatide · 22 Oct 2025 · 0 likes Worth separating two things that post #60 runs together. The five maintenance doses in the tirzepatide programme give a genuine dose-response curve, which is unusual.…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #39 · Safety › Adverse events · 20 Oct 2025 · 4 likes On post #37 — agreed on the reasoning, with one qualification. Injection-site reactions that spread over a day or come with systemic symptoms are a different…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #16 · Start Here › Welcome · 13 Oct 2025 · 7 likes The category structure looks heavier than it is. There are twenty top-level categories and you will use three of them. Find those three, mute the rest for a month, and…
-
A comparison of home results against a laboratory result on the same vial Replied, post #46 · Analytics › Home & field testing · 7 Oct 2025 · 2 likes A home refractometer is not measuring what people hope it is measuring in these preparations, and the readings are dominated by everything other than the peptide. A…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #66 · Sourcing › Vendor reports · 2 Oct 2025 · 4 likes I had written a reply contradicting post #62 and deleted it. Here is what survived. I would rather this thread reach "we do not know" about vendor documentation pages…
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #52 · Evidence › Preprints · 29 Sep 2025 · 10 likes Where a preprint contradicts a published trial, the prior should favour the trial. Where it extends one, the preprint can be genuinely useful.
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #16 · Sourcing › Vendor reports · 17 Sep 2025 · 0 likes Reports of ordinary results are more valuable than reports of remarkable ones, precisely because only the remarkable ones get posted elsewhere. That matches what I was…
-
Coming back to: Oxidation and deamidation mass shifts, tabulated Replied, post #36 · Analytics › Mass spectrometry · 14 Sep 2025 · 0 likes Adducts — sodium and potassium especially — shift the observed mass in predictable increments. A report showing an unexplained plus twenty-two is usually showing you a…
-
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #49 · Practice › Dosing & titration · 6 Sep 2025 · 8 likes Post #45 describes the usual case. This is about the unusual one. When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent…
-
Vagal afferents and the gut-brain pathway — one year on Replied, post #2 · Pharmacology › Receptor biology · 1 Sep 2025 · 2 likes Biased agonism — where different ligands at the same receptor favour different downstream pathways — is a plausible explanation for differences between compounds in…
-
Hypertension improvement and when medication needs revisiting Replied, post #28 · Clinical › Comorbidities · 27 Aug 2025 · 1 like The arithmetic in post #25 is right; the assumption feeding it is the part to check. Bariatric surgery history: altered anatomy after surgery affects absorption. That…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #79 · Evidence › Journal club · 21 Aug 2025 · 8 likes The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to. Posted with…
-
When a preprint is the best available evidence and we say so Replied, post #78 · Evidence › Preprints · 20 Aug 2025 · 21 likes Before the thread moves on from preprint — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n of four and…
-
Revisiting: Why I ask for the gradient before I discuss the number Replied, post #15 · Analytics › HPLC & UHPLC · 15 Aug 2025 · 5 likes Post #13 and I disagree about the size of the effect, not about the direction. Column temperature affects retention and selectivity and is omitted from most…
-
Sequence verification for an obscure compound: how it is done Replied, post #97 · Compounds › Other compounds · 19 Jul 2025 · 17 likes Helpful, and short, which on this subject is harder than long.
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #127 · Compounds › Tirzepatide · 4 Jul 2025 · 0 likes Post #124 is right about the mechanism and I think understates the practical bit. Answering the tirzepatide in type 2 diabetes question as asked, then the question I…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #106 · Compounds › Cagrilintide & amylin analogues · 15 Jun 2025 · 2 likes Coming back to post #102, because the follow-up matters more than the original answer. On storage: aggregation-prone peptides are the ones where repeated warming and…
-
Second pass at: Semaglutide and alcohol: what is actually documented Replied, post #11 · Compounds › Semaglutide · 8 Jun 2025 · 0 likes Confirming post #10 from a second method, which matters more than confirming it from a second person. An update on my earlier Semaglutide and alcohol post: the pattern…
-
Second pass at: Pen dose counters: what a click does and does not guarantee Replied, post #55 · Devices › Pens & autoinjectors · 1 Jun 2025 · 31 likes Bookmarking this. I will come back when I have something worth adding.
-
Reading a chromatogram someone posted without axes Replied, post #37 · Analytics › HPLC & UHPLC · 25 May 2025 · 0 likes On reading a chromatogram, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the range is the…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #3 · Compounds › Semaglutide · 21 May 2025 · 0 likes I read the opening post twice before replying, because I had assumed the opposite. The 2.4 mg maintenance dose in the weight-management programme and the 1.0 mg…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #88 · Clinical › Comorbidities · 18 May 2025 · 8 likes Post #84 describes the usual case. This is about the unusual one. The version of obstructive sleep apnoea that I was taught turned out to be a teaching simplification.…
-
Asking about a compound your prescriber has not heard of Replied, post #33 · Clinical › Prescriber conversations · 7 May 2025 · 10 likes Post #31 is the version of this I will quote in future. One addition. Asking what monitoring is planned and why makes the monitoring make sense, and makes it likelier…
-
Adducts: sodium, potassium, and the peak you did not expect Replied, post #71 · Analytics › Mass spectrometry · 18 Apr 2025 · 9 likes On adducts I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is how threads get…
-
Reading order for a first week here, and what to skip until later Replied, post #77 · Start Here › Welcome · 11 Apr 2025 · 2 likes Reading the guidelines before you post is genuinely worth the twenty minutes. Not because you will break one, but because the rules explain why the place reads the way…
-
Antibiotics and a course of something with delayed emptying Replied, post #12 · Practice › Interactions · 31 Mar 2025 · 9 likes Delayed gastric emptying is the mechanism behind most of the plausible interactions in this class: anything whose absorption depends on how quickly the stomach empties…
-
A promotion I argued against, and why I lost Replied, post #138 · Documentation › Doc review · 18 Mar 2025 · 6 likes Answering the question post #136 raises rather than the one it answers. The claim about promotion upthread is stronger than its source supports. I have read the source.…
-
Maintainer handover: how it works Replied, post #70 · Meta › Wiki maintenance · 18 Mar 2025 · 0 likes Volunteering for the review on this one. I use it monthly, I have a list of three things that have aged badly, and I am willing to be named as the second maintainer.
-
A supplier that answers analytical questions with restated claims Replied, post #40 · Sourcing › Red flags · 16 Mar 2025 · 6 likes Narrowing post #37, because the general version has more than one answer. Safety documentation absent: a supplier that cannot provide information about sterility…
-
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #49 · Pharmacology › Receptor biology · 12 Feb 2025 · 5 likes Where I part company with post #45, and it is a narrow parting. Taking Biased agonism seriously for a moment rather than deflecting: the honest position is that the…
-
Consistent declarations and why they matter more than clever ones Replied, post #9 · Sourcing › Logistics · 8 Feb 2025 · 31 likes I read post #7 twice before replying, because I had assumed the opposite. Peak periods and public holidays affect this more than any other factor and are entirely…
-
Follow-up: Oral contraceptives and delayed emptying: what the data shows Replied, post #34 · Practice › Interactions · 3 Jan 2025 · 17 likes Oral contraceptives and delayed emptying: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to…
-
Persistent vomiting and the threshold for seeking help — one year on Replied, post #18 · Safety › Adverse events · 20 Dec 2024 · 4 likes The claim about Persistent vomiting upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says "causes".
-
Coming back to: Renal impairment: what the labelling says about dose Replied, post #22 · Clinical › Special populations · 16 Dec 2024 · 11 likes Hepatic impairment: less is known about dosing in significant liver disease than in kidney disease. Extreme caution applies because the liver metabolises a large…
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #8 · Practice › Side effects · 17 Nov 2024 · 9 likes A definition problem is doing most of the work in this injection-site reactions discussion. Once the term is pinned down I suspect the disagreement mostly goes away and…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #63 · Analytics › COA interpretation · 23 Sep 2024 · 3 likes I read post #61 twice before replying, because I had assumed the opposite. Practical answer on field-by-field walk through a certificate, since the theoretical one is…
-
How this community labels and discusses unrefereed work Replied, post #111 · Evidence › Preprints · 25 Jul 2024 · 11 likes One more thing on community labels that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the…
-
Journal club: FLOW and the renal composite, component by component Replied, post #36 · Evidence › Journal club · 12 Jul 2024 · 26 likes The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping.…